Open Accessβ-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study
Author(s) -
Sameh A. Lashen,
Mohammed Mohammed Shamseya,
M. A. Madkour,
Radwa M Abdel Salam,
Sanaa S Mostafa
Publication year - 2022
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v14.i2.429
Subject(s) - medicine , portal hypertension , gastroenterology , cirrhosis , liver biopsy , cardiology , biopsy
Portal hypertension, a common complication associated with liver cirrhosis, can result in variceal bleeding, which greatly impacts patient survival. Recently, β-arrestin-2 has been shown to predict the acute hemodynamic response to nonselective β-blocker therapy for cirrhotic portal hypertension. However, more data is needed on the long-term effects of and changes in β-arrestin-2 following nonselective β-blocker therapy.